Outcome of the Board Meeting under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Awaiting price reaction for this filing.
The Board of Directors approved the unaudited financial results for Q1 FY26 (quarter ended June 30, 2025). Total income stood at Rs. 86,923.72 lakhs, up from Rs. 82,052.17 lakhs in Q1 FY25, driven by revenue from contracts of Rs. 86,215.89 lakhs. Profit before tax rose sharply to Rs. 8,284.32 lakhs (vs Rs. 6,795.30 lakhs), while profit after tax jumped to Rs. 6,163.12 lakhs (vs Rs. 4,390.98 lakhs), a ~40% YoY increase. Basic EPS stood at Rs. 5.20 compared to Rs. 3.70 in the year-ago quarter. Finance costs fell notably to Rs. 1,688.29 lakhs from Rs. 2,521.78 lakhs, aiding profitability. The results carry an Emphasis of Matter from auditors on the pending urea subsidy dispute (Rs. 2,914 lakhs from FY21) and the proposed merger with Paradeep Phosphates Limited, which is awaiting regulatory approvals. Urea concession income continues to be booked based on management estimates pending Government of India finalization.
Strong earnings growth driven by lower finance costs and margin stability should be positive for shareholders, though the pending subsidy litigation and ongoing merger process introduce uncertainty around the stock's near-term direction.